See our new webpage about the GA-map® Dysbiosis Test

Visit page

Skip to content

Home
About us
Products
- Service Products
  - The GA-map® Dysbiosis Test Lx
  - The GA-map® COVID-19 Fecal Test Kit
- Lab Products
  - The GA-map® Dysbiosis Lx reagent kit
  - The GA-map® COVID-19 reagent kit
News
- Press Releases
- News
For Investors
Order
Contact us

Home
About us
Products
- Service Products
  - The GA-map® Dysbiosis Test Lx
  - The GA-map® COVID-19 Fecal Test Kit
- Lab Products
  - The GA-map® Dysbiosis Lx reagent kit
  - The GA-map® COVID-19 reagent kit
News
- Press Releases
- News
For Investors
Order
Contact us

Eilert Aamodt

Genetic Analysis AS: Mandatory notification of trade – Primary Insiders

2023-05-26

Genetic Analysis presents at Sedermeradagen 2023 in Stockholm

2023-05-25

Interim report January–March 2023

2023-05-25

Minutes from the Annual General Meeting 2023 in Genetic Analysis AS

2023-05-11

Notice of Annual General Meeting 2023

2023-04-28

Publication of Genetic Analysis’ 2022 Annual Report

2023-04-20

Genetic Analysis presents at Mangold Insight’s Investor Day

2023-03-17

Year-end report January – December 2022

2023-03-172023-02-17

Genetic Analysis strengthens and future-proofs the organization

2023-01-312023-01-31

Genetic Analysis’ CTO finalist in the Lyfebulb and Bristol Myers Squibb Innovation Challenge addressing unmet needs in IBD

2023-02-022023-01-27

Post navigation

Older posts

Page1 Page2 … Page5 Next →

Genetic Analysis AS is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.

Contact

Phone: +47 48 32 16 10
E-mail: info@genetic-analysis.com
Address: Genetic Analysis AS, Ulvenveien 80B
0581 Oslo, Norway

Open Google Maps

Connect

Navigate

© 2023 Genetic Analysis

Home
About us
Products
- Service Products
  - The GA-map® Dysbiosis Test Lx
  - The GA-map® COVID-19 Fecal Test Kit
- Lab Products
  - The GA-map® Dysbiosis Lx reagent kit
  - The GA-map® COVID-19 reagent kit
News
- Press Releases
- News
For Investors
Order
Contact us